Suppr超能文献

不同的免疫反应性表明大鼠脂蛋白脂肪酶中存在潜在的组织变体。

Distinct immunoreactivities suggest the existence of potential tissue variants in rat lipoprotein lipase.

作者信息

Soteriou A, Cryer A

机构信息

Department of Biochemistry, University of Wales College of Cardiff, U.K.

出版信息

Biochem J. 1994 Apr 15;299 ( Pt 2)(Pt 2):417-23. doi: 10.1042/bj2990417.

Abstract

Lipoprotein lipases (LPL) isolated from rat cardiac muscle and bovine milk were each used as immunogens to produce polyclonal anti-LPL sera and two anti-LPL monoclonal antibodies. The immunological reactivities of these antibody sources with LPL purified from rat cardiac muscle, lung, adipose tissue, mammary gland and skeletal muscle were compared by an e.l.i.s.a. and by Western blotting. Differences between the immunoreactivities of LPL from the distinct tissue sources were revealed in both systems. A synthetic peptide with a sequence corresponding to the heparin-binding site of LPL (Ser-Arg-Thr-Asn-Thr-Lys-Val-Ser-Arg-Ile-Thr-Gly-Leu) was produced and used as an immunogen. The antiserum produced against the synthetic peptide was found to bind specifically to the region of the heparin-binding site, as determined by use of a competition e.l.i.s.a. In use against the five tissue LPL preparations, this antiserum revealed only minor variations between the tissue sources, compared with the hierarchy of reactivity observed when antibodies raised against the whole molecule were used. In combination with the outcome of previous studies on some of the physical properties of these preparations [Soteriou and Cryer (1993) Int. J. Biochem. 25, 1483-1490], the observations reported here on the distinct immunoreactivities exhibited by LPL prepared from the different tissue sources of a single species indicate the necessity to characterize fully the nature of these differences.

摘要

从大鼠心肌和牛乳中分离出的脂蛋白脂肪酶(LPL)分别用作免疫原,以产生多克隆抗LPL血清和两种抗LPL单克隆抗体。通过酶联免疫吸附测定(ELISA)和蛋白质免疫印迹法比较了这些抗体来源与从大鼠心肌、肺、脂肪组织、乳腺和骨骼肌中纯化的LPL的免疫反应性。在这两种系统中均揭示了不同组织来源的LPL免疫反应性之间的差异。合成了一种与LPL肝素结合位点序列相对应的肽(Ser-Arg-Thr-Asn-Thr-Lys-Val-Ser-Arg-Ile-Thr-Gly-Leu)并用作免疫原。通过竞争ELISA测定发现,针对合成肽产生的抗血清特异性结合肝素结合位点区域。在针对五种组织LPL制剂的使用中,与使用针对整个分子产生的抗体时观察到的反应性层次相比,该抗血清仅揭示了组织来源之间的微小差异。结合先前关于这些制剂某些物理性质的研究结果[Soteriou和Cryer(1993年)《国际生物化学杂志》25,1483 - 1490],此处报道的关于从单一物种的不同组织来源制备的LPL表现出的不同免疫反应性的观察结果表明,有必要充分表征这些差异的本质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18dd/1138288/102d80d37132/biochemj00089-0102-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验